Single nucleotide polymorphism in CPT1B and CPT2 genes and its association with blood carnitine levels in acute myocardial infarction patients
详细信息 查看全文
- 作者：Haseeb Ahmad Khan ; khan_haseeb@yahoo.com ; haseeb@ksu.edu.sa ; Abdullah Saleh Alhomida
- 关键词：AMI ; acute myocardial infarction ; BMI ; body mass index ; CAD ; coronary artery disease ; CoA ; coenzyme A ; CPT1B ; carnitine palmitoyltransferase IB ; CPT2 ; carnitine palmitoyltransferase II ; dbSNP ; database of single nucleotide polymorphism ; DNA ; deoxyribonucl
- 刊名：Gene
- 出版年：2013
- 出版时间：1 July, 2013
- 年：2013
- 卷：523
- 期：1
- 页码：76-81
- 全文大小：470 K
文摘
Ischemic and reperfusion injuries in acute myocardial infarction (AMI) lead to mitochondrial dysfunction in heart cells. Lipid metabolism takes place in mitochondria where carnitine palmitoyltransferase (CPT) enzyme system facilitates the transport of long-chain fatty acids into matrix to provide substrates for beta-oxidation. We sequenced the coding regions of CPT1B and CPT2 genes to identify the single nucleotide polymorphism (SNP) in 23 AMI patients and 23 normal subjects. We also determined blood carnitine levels in these samples to study the impact of these SNPs on carnitine homeostasis. The sequencing of coding regions revealed 4 novel variants in CPT1B gene (G320D, S427C, E531K, and A627E) and 2 variants in CPT2 gene (V368I and M647V). There were significant increases in total carnitine (54.18 ¡À 3.11 versus 21.49 ¡À 1.03 ¦Ìmol/l) and free carnitine (37.78 ¡À 1.87 versus 10.06 ¡À 0.80 ¦Ìmol/l) levels in AMI patients as compared to normal subjects. CPT1B heterozygous variants of G320D and S427C among control subjects showed significantly higher levels of total and free carnitine in the blood. The homozygous genotype (AA) of CPT2 variant V368I had significantly less blood carnitine in AMI patients. Serum troponin T was significantly less in GG genotype of CPT1B variant S427C whereas the genotype AA of CPT2 variant V368I showed significantly higher serum troponin T levels. Further studies on large number of patients are necessary to confirm the role of CPT1B and CPT2 polymorphism in AMI.